Abstract
Purpose
To compare the efficacy, safety and patient comfort of two topical steroids (prednisolone 1% and rimexolone 1%) and a topical non-steroidal anti-inflammatory agent (ketorolac tromethamine 0.5%) after extracapsular cataract extraction.
Methods
Forty-five patients were enrolled in this prospective, randomized, double-blind study. They were assigned to receive topical treatment with either prednisolone, rimexolone or ketorolac tromethamine ophthalmic solution after phacoemulsification for cataract extraction. On postoperative days 1, 3, 5, 14 and 28 best-corrected visual acuity, intraocular pressure (IOP), slit-lamp examination of the anterior segment and report of the patients’ comfort were assessed and compared by Friedman rank time analysis.
Results
Regarding the primary outcome efficacy of inflammation control the assessment of cells did not differ (p=0.165), while flare in the anterior chamber was lowest (p=0.008) in the non-steroidal anti-inflammatory drug (NSAID) group. Surface inflammation was lowest with prednisolone (p=0.002). Regarding safety, visual acuity did not differ among the groups. In the prednisolone group one patient, however, responded to steroid treatment with elevated IOP and had to be excluded. In the remaining patients IOP was even lower in the two steroidal treatment groups than with ketorolac (p=0.030). One patient receiving ketorolac had to be excluded because a corneal erosion developed. Patient comfort was highest with prednisolone (p=0.041).
Conclusions
Ketorolac tromethamine provides good control of intraocular inflammation after cataract extraction without the risk of a steroidal IOP increase, which was also not observed under rimexolone therapy. The best surface inflammation control and patient comfort was observed with prednisolone, which remains a good choice.
This is a preview of subscription content, access via your institution.
References
Armaly, MF (1963) Effects of corticosteroids on intraocular pressure and fluid dynamics. 1. The effect of dexamethasone in the normal eye. Arch Ophthalmol 70:482–491
Brennan KM, Brown RM, Roberts CW (1993) A comparison of topical non-steroidal anti-inflammatory drugs to steroids for control of post cataract inflammation. Insight 18:8–11
Bron A, Denis P, Hoang-Xuan TC, Boureau-Andrieux C, Crozafon P, Hachet E, Medhorn E, Akingbehin A (1998) The effects of rimexolone 1% in postoperative inflammation after cataract extraction. A double-masked placebo-controlled study. Eur J Ophthalmol 8:16–21
Demco TA, Sutton H, Demco CJ et al (1997) Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification–lens implant surgery. Eur J Ophthalmol 7:236–240
El-Harazi SM, Ruiz RS, Feldman RM et al (1998) A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 1.0% and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. Ophthalmic Surg Lasers 20:539–544
Flach AJ, Jaffe NS, Akers WA (1989) The effect of ketorolac tromethamine in reducing postoperative inflammation: double-mask parallel comparison with dexamethasone. Ann Ophthalmol 21:407–411
Flach AJ, Stegman RC, Graham J et al (1990) Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology 97:1253–1258
Gass JDM, Norton EWD (1966) Cystoid macular edema and papilledema following cataract extraction: a fluorescein fundoscopic and angiographic study. Arch Ophthalmol 76:646–661
Guidera AC, Luchs JI, Udell IJ (2001) Keratitis, ulceration and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology 108:936–944
Heier J, Cheetham JK, DeGryse R et al (1999) Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Am J Ophthalmol 127:253–259
Leibowitz HM, Bartlett JD, Rich R et al (1996) Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids. Arch Ophthalmol 114:933–937
Neufeld AH, Sears ML (1973) Prostaglandin and eye. Prostaglandins 4:157–175
Ostrov CS, Sirkin SR, Deutsch WE et al (1997) Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clin Ther 19:259–272
Roberts CW, Brennan KM (1995) A comparison of topical diclofenac with prednisolone for postcataract inflammation. Arch Ophthalmol 113:725–727
Snyder RW, Siekert RW, Schwiegerling J, Donnenfeld E, Thompson P (2000) Acular as a single agent for use as an antimiotic and anti-inflammatory in cataract surgery. J Cataract Refract Surg 26:1225–1227
Solomon KD, Vroman DT, Barker D et al (2001) Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Prospective randomized double-masked study. J Cataract Refract Surg 27:1232–1237
Waterbury L, Kunysz EA, Beuerman R (1987) Effects of steroidal and non-steroidal anti-inflammatory agents on corneal wound healing. J Ocul Pharmacol 3:43–54
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have no proprietary interest in any of the equipment or materials used in this study.
Rights and permissions
About this article
Cite this article
Hirneiß, C., Neubauer, A.S., Kampik, A. et al. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction. Graefe's Arch Clin Exp Ophthalmol 243, 768–773 (2005). https://doi.org/10.1007/s00417-005-1126-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-005-1126-9
Keywords
- Extracapsular cataract extraction
- Prednisolone acetate
- Rimexolone
- Ketorolac tromethamine
- Non-steroidal anti-inflammatory drug